Fennec Pharmaceuticals Inc. (FENC)

NASDAQ: FENC · Real-Time Price · USD

11.62

+0.72 (6.61%)

Nov 13, 2026, 4:00 PM EST - Market closed

Fennec Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	2.03	-9.74	-0.44	-16.05	-23.71	-17.35
Other Amortization	0.03	0.07	0.16	0.29	0.15	0.02
Loss (Gain) From Sale of Investments	-	0	0.08	0.04	0.18	0.03
Stock-Based Compensation	6.64	7.03	5.06	5.35	4.22	4.01
Provision & Write-off of Bad Debts	1.81	2.21	4.6	-	-	-
Other Operating Activities	3.31	2.8	0.57	-	-	-
Change in Accounts Receivable	-3.69	-12.44	-7.87	-7.27	-1.55	-
Change in Inventory	-0.41	-1.28	0.58	-1.58	-0.58	-
Change in Accounts Payable	-1.26	1.39	-0.54	1.39	1.61	-0.79
Change in Unearned Revenue	-0.89	-	24.81	-	-	-
Change in Other Net Operating Assets	-4.41	-2.51	-0.04	0.68	1.61	-0.14
Operating Cash Flow	3.15	-12.47	26.98	-17.14	-18.06	-14.22
Operating Cash Flow Growth	-	-	-	-	-	-

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Long-Term Debt Issued	-	-	-	5	25.17	5
Long-Term Debt Repaid	-	-19.48	-13	-	-5	-0.01
Net Debt Issued (Repaid)	-19.48	-19.48	-13	5	20.17	4.99
Issuance of Common Stock	46.44	44.24	1.3	1.72	0.93	0.03
Repurchase of Common Stock	-1.43	-0.19	-0.18	-0.08	-0.19	-
Other Financing Activities	-1.95	-1.95	-1.74	-	-0.18	-0.04
Financing Cash Flow	23.59	22.63	-13.62	6.64	20.73	4.98

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash Flow	26.74	10.15	13.37	-10.51	2.67	-9.24

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Levered Free Cash Flow	4.06	-7.33	-0.29	-12.35	-9.17	-7.73
Unlevered Free Cash Flow	4.24	-6.06	2.15	-10.34	-8.61	-7.66

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash Interest Paid	4.16	4.16	3.82	-	-	-
Cash Income Tax Paid	0.75	0.75	-	-	-	-
Change in Working Capital	-10.67	-14.83	16.94	-6.78	1.1	-0.93

SEC Filings: 10-K · 10-Q